cisplatin,pembrolizumab,gemcitabine,pemetrexed
merck
['kn671', 'nsclc', 'pembro', 'sclc']
the #oncoalerttoptweet day 2 #asco23 tweet by faculty kn671 ph iii neoadj chemo-pembro + 1 yr adjuvant io in early stage nsclc - screened &gt;1300pts - 84%pts completed 3 neoadj cycles, 75% 4 cycles best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨